May 29, 2020 | National Law Journal
Prosecutors Are Taking Aim at Medical Technology Companies. Here Are the Biggest Risk AreasAs the COVID-19 pandemic continues to bolster increased federal spending on health care, medtech companies should expect close scrutiny from federal prosecutors, particularly where conduct poses a risk to patient health and safety.
By John Bentivoglio, Jennifer Bragg, Maya Florence and Pamela Amaechi
6 minute read
January 31, 2020 | National Law Journal
Drug and Device Manufacturers Remain in DOJ's CrosshairsThe DOJ continues to make strides in the fraud and abuse sector for life sciences against drug and device manufacturers.
By John Bentivoglio, Jennifer Bragg, Maya Florence and Elizabeth Berry
5 minute read
Trending Stories